EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

High‐dose folic acid use and cancer risk in women who have given birth: A register‐based cohort study

Håkon Magne Vegrim iD, Julie Werenberg Dreier iD, Jannicke Igland iD, Silje Alvestad iD, Nils Erik Gilhus iD, Mika Gissler iD, Maarit K Leinonen iD, Torbjörn Tomson iD, Helga Zoega iD, Jakob Christensen iD, Marte-Helene Bjørk iD

Epilepsia · 2025-01 · 66 (1) · 75-88

DOI: 10.1111/epi.18146 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Epilepsia, online erschienen am 14.11.2024. Verfasst von Håkon Magne Vegrim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, University of Bergen, Bergen, Norway. Hauptthemen laut MEDLINE: Folic Acid, Neoplasms, Epilepsy, Pregnancy Complications. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NordForsk.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study was undertaken to study whether high‐dose folic acid ( > 1 mg daily) use is associated with an increased risk of cancer in all women who have given birth and in women with epilepsy. High‐dose folic acid supplementation during pregnancy has been linked to increased cancer risk in children born to mothers with epilepsy.

Methods

We identified women with their first pregnancy in Denmark (1997–2017), Norway (2005–2017), and Sweden (2006–2017) using medical birth registers, linking individual data across nationwide health registers and statistical agencies. Exposure was defined as filled prescriptions for high‐dose folic acid, considered time‐varyingly. The primary outcome was the first malignant cancer diagnosis. Hazard ratios (HRs) of cancer after high‐dose folic acid exposure were estimated using Cox proportional hazard models with 95% confidence intervals (CIs), adjusted for confounders including antiseizure medication (ASM) use, and stratified by maternal epilepsy diagnosis. A 6‐month time lag was applied, as cancer is unlikely to develop immediately.

Results

With up to 21 years of follow‐up, we identified 1 465 785 women who gave birth, including 64 485 (4.4%) exposed to high‐dose folic acid. In the exposed group, 755 cancer cases were observed (208 per 100 000 person‐years, 95% CI = 193.8–223.5), compared with 18 702 cases in the unexposed group (164 per 100 000 person‐years, 95% CI = 161.5–166.2), yielding a 20% increased cancer risk overall (adjusted HR = 1.2, 95% CI = 1.1–1.2). This risk was attenuated after the 6‐month lag analysis (adjusted HR = 1.1, 95% CI = 1.04–1.2). The risk for non‐Hodgkin lymphoma was increased in all analyses ( n = 28, adjusted HR = 2.0, 95% CI = 1.3–2.9). The association between high‐dose folic acid use and overall cancer risk was similar in those with epilepsy regardless of ASM use (adjusted HR = 1.3, 95% CI = 1.0–1.8). Significance High‐dose folic acid use was associated with increased overall cancer risk in women who have given birth, with a consistent association with non‐Hodgkin lymphoma, including those with epilepsy, regardless of ASM use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Folic AcidNeoplasmsEpilepsyPregnancy ComplicationsPrenatal Exposure Delayed EffectsHumansFemaleRegistriesAdultPregnancyCohort StudiesDenmarkYoung AdultNorwaySwedenRisk Factors

Stichwörter der Autor:innen

antiseizure medicationepilepsyfolic acidneoplasmswomen's Health

Substanzen

Folic Acid

Autor:innen und Institutionen

  • Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • National Center for Register-Based Research, School of Business and Social Sciences, Aarhus University, Aarhus, Denmark.
  • Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
  • Department of Health and Caring Sciences, Western Norway University of Applied Sciences, Bergen, Norway.
  • National Center for Epilepsy, Oslo University Hospital, Oslo, Norway.
  • Department of Neurology, Haukeland University Hospital, Bergen, Norway.

ORCID-Profile: Håkon Magne Vegrim, Julie Werenberg Dreier, Jannicke Igland, Silje Alvestad, Nils Erik Gilhus, Mika Gissler, Maarit K Leinonen, Torbjörn Tomson, Helga Zoega, Jakob Christensen, Marte-Helene Bjørk

Förderung

  • NordForsk

Zitieren

APA

Vegrim, H. M., Dreier, J. W., Igland, J., Alvestad, S., Gilhus, N. E., Gissler, M., Leinonen, M. K., Tomson, T., Zoega, H., Christensen, J., & Bjørk, M. H. (2025). High‐dose folic acid use and cancer risk in women who have given birth: A register‐based cohort study. Epilepsia, 66(1), 75-88. https://doi.org/10.1111/epi.18146

Vancouver

Vegrim HM, Dreier JW, Igland J, Alvestad S, Gilhus NE, Gissler M, et al. High‐dose folic acid use and cancer risk in women who have given birth: A register‐based cohort study. Epilepsia. 2025;66(1):75-88. doi:10.1111/epi.18146

BibTeX
@article{Vegrim2025,
  author = {Vegrim, Håkon Magne and Dreier, Julie Werenberg and Igland, Jannicke and Alvestad, Silje and Gilhus, Nils Erik and Gissler, Mika and Leinonen, Maarit K and Tomson, Torbjörn and Zoega, Helga and Christensen, Jakob and Bjørk, Marte-Helene},
  title = {High‐dose folic acid use and cancer risk in women who have given birth: A register‐based cohort study},
  journal = {Epilepsia},
  year = {2025},
  volume = {66},
  number = {1},
  pages = {75--88},
  doi = {10.1111/epi.18146}
}
Kostenlos starten →